🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04741789
Treatments Being Tested
The purpose was to evaluate the efficacy and safety of the combination of c...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-01-22
Trial ID
NCT04139317
Treatments Being Tested
The purpose of this study of capmatinib (INC280) and spartalizumab (PDR001)...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-15
Trial ID
NCT02795429
Treatments Being Tested
This is a Phase II, two parallel group study assessing the efficacy and saf...
Status
Not Yet Recruiting
Location
Cancer Center of Sun-Yat Sen University
Start Date
2024-02-01
Trial ID
NCT06054191
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested
The primary purpose of the Phase II CLGX818X2102 study is to assess the ant...
Status
Terminated
Location
Sarah Cannon Research Institute Onc Dept
Start Date
2013-11
Trial ID
NCT01820364
Treatments Being Tested
INC280 will be administered to Japanese patients with advanced soid tumors ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01546428
Treatments Being Tested
Drg-drug Interaction (DDI) study to assess the effect of INC280 on the phar...
Status
Completed
Location
Emory University School of Medicine/Winship Cancer Institute SC-2
Start Date
2015-12-10
Trial ID
NCT02520752
The study assessed the safety and the dose of the combination of INC280 and...
Status
Terminated
Location
Dana Farber Cancer Institute SC
Start Date
2014-01-09
Trial ID
NCT01870726
Treatments Being Tested
This was an open-label, phase Ib, multicenter clinical trial to determine t...
Status
Terminated
Location
Massachusetts General Hospital Head & Neck
Start Date
2014-07-28
Trial ID
NCT02205398